Ono, PeptiDream in Deal for Macrocyclic Constrained Peptide Therapeutics

March 16, 2023
Ono Pharmaceutical said on March 15 that it has sealed a drug discovery collaboration pact with PeptiDream to discover and develop novel macrocyclic constrained peptide drugs against multiple targets of Ono’s interest. Ono did not disclose the specific therapeutic areas...read more